Neonatal herpes simplex virus infection. 1975

R J Whitley, and L T Ch'ien, and C A Alford

These results suggest that Ara A, within its nontoxic dose range, may be efficacious in the treatment of neonatal HSV infection, provided the drug is given early in the course of the disease. Such studies as this have prompted a large scale multi-institutional study, which hopefully will provide a greater insight into the natural history of this usually devastating disease. The information gathered undoubtedly will lead to better and more specific antiviral agents as well as diagnostic techniques for earlier identification of neonatal HSV disease.

UI MeSH Term Description Entries
D007065 Idoxuridine An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent. 5-Iodo-2'-deoxyuridine,IUdR,Iododeoxyuridine,5-Iododeoxyuridine,Allergan 211,Herplex Liquifilm,Idoxuridine, 123I-Labeled,Idoxuridine, 125I-Labeled,Idoxuridine, 131I-Labeled,Idoxuridine, 3H-Labeled,Idoxuridine, Radical Ion (+1),Idoxuridine, Radical Ion (1-),Kerecide,NSC-39661,Oftan-IDU,SK&F-14287,Stoxil,123I-Labeled Idoxuridine,125I-Labeled Idoxuridine,131I-Labeled Idoxuridine,3H-Labeled Idoxuridine,5 Iodo 2' deoxyuridine,5 Iododeoxyuridine,Idoxuridine, 123I Labeled,Idoxuridine, 125I Labeled,Idoxuridine, 131I Labeled,Idoxuridine, 3H Labeled,Liquifilm, Herplex,NSC 39661,NSC39661,Oftan IDU,OftanIDU
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007635 Keratitis, Dendritic A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed) Furrow Keratitis,Keratitis, Furrow,Dendritic Keratitides,Dendritic Keratitis,Furrow Keratitides,Keratitides, Dendritic,Keratitides, Furrow
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006559 Pemphigoid Gestationis An itching, autoimmune, bullous SKIN disease that occurs during the last two trimesters of PREGNANCY and PUERPERIUM. It also affects non-pregnant females with tissue of PLACENTA origin, such as CHORIOCARCINOMA; or HYDATIDIFORM MOLE. It exhibits antigenic and clinical similarity to bullous pemphigoid (PEMPHIGOID, BULLOUS). This disease does not involve herpes viruses (old name, herpes gestationis). Gestational Pemphigoid,Herpes Gestationis,Gestational Pemphigoids,Gestationi, Pemphigoid,Gestationis, Pemphigoid,Pemphigoid Gestationi,Pemphigoid, Gestational,Pemphigoids, Gestational
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014740 Vidarabine A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus. Adenine Arabinoside,Ara-A,Arabinofuranosyladenine,Arabinosyladenine,9-beta-Arabinofuranosyladenine,9-beta-D-Arabinofuranosyladenine,Ara A,Vira-A,alpha-Ara A,alpha-D-Arabinofuranosyladenine,beta-Ara A,9 beta Arabinofuranosyladenine,9 beta D Arabinofuranosyladenine,Arabinoside, Adenine,Vira A,ViraA,alpha Ara A,alpha D Arabinofuranosyladenine,beta Ara A

Related Publications

R J Whitley, and L T Ch'ien, and C A Alford
June 2004, Current opinion in infectious diseases,
R J Whitley, and L T Ch'ien, and C A Alford
March 1997, Clinics in perinatology,
R J Whitley, and L T Ch'ien, and C A Alford
September 2015, Infectious disease clinics of North America,
R J Whitley, and L T Ch'ien, and C A Alford
March 2023, The New England journal of medicine,
R J Whitley, and L T Ch'ien, and C A Alford
December 2012, Clinical obstetrics and gynecology,
R J Whitley, and L T Ch'ien, and C A Alford
August 2009, Seminars in fetal & neonatal medicine,
R J Whitley, and L T Ch'ien, and C A Alford
November 1992, Journal of the American Academy of Dermatology,
R J Whitley, and L T Ch'ien, and C A Alford
November 2003, Archives of disease in childhood. Fetal and neonatal edition,
R J Whitley, and L T Ch'ien, and C A Alford
January 1981, Perspectives in pediatric pathology,
R J Whitley, and L T Ch'ien, and C A Alford
January 2001, Paediatric drugs,
Copied contents to your clipboard!